In conclusion, our data indicate that pulmonary rather than systemic IL-17A is important for obesity-related AHR and suggest that changes in pulmonary Cfd expression contribute to these effects of IL-17A. The gene discussed is IL17A; the disease is obesity due to melanocortin 4 receptor deficiency.